Table 5 Menstruation outcomes before or after UFs treated by UAE or MYO.
Menstrual Bleeding | Study number | Events/Simple Size | Statistical Method | Effect Estimate | Heterogeneity (I2) | Overall effect | |
|---|---|---|---|---|---|---|---|
UAE | MYO | ||||||
Baseline | |||||||
Amenorrhea | 2 | 0/142 | 1/140 | Risk Difference (M–H, Fixed, 95% CI) | − 0.01 [− 0.03, 0.02] | 0% | P = 0.54 |
Light | 2 | 0/142 | 4/140 | Odds Ratio (M–H, Fixed, 95% CI) | 0.19 [0.02, 1.65] | 0% | P = 0.13 |
Normal | 2 | 51/142 | 36/140 | Odds Ratio (M–H, Random, 95% CI) | 1.40 [0.53, 3.72] | 67% | P = 0.50 |
Heavy | 2 | 91/142 | 99/140 | Odds Ratio (M–H, Random, 95% CI) | 0.90 [0.27, 2.98] | 78% | P = 0.87 |
Follow-up | |||||||
Amenorrhea | 2 | 15/91 | 15/83 | Odds Ratio (M–H, Fixed, 95% CI) | 0.80 [0.35, 1.84] | 0% | P = 0.60 |
Light | 2 | 31/91 | 35/83 | Odds Ratio (M–H, Fixed, 95% CI) | 1.83 [0.58, 5.80] | 0% | P = 0.31 |
Normal | 2 | 26/91 | 25/83 | Odds Ratio (M–H, Fixed, 95% CI) | 0.50 [0.05, 4.72] | 59% | P = 0.55 |
Heavy | 2 | 11/91 | 10/83 | Odds Ratio (M–H, Fixed, 95% CI) | 0.96 [0.38, 2.42] | 0% | P = 0.93 |
